ISE Chemicals Corporation
ICHMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33,287,000 | $26,413,000 | $25,564,000 | $20,354,000 |
| % Growth | 26% | 3.3% | 25.6% | – |
| Cost of Goods Sold | $23,178,000 | $19,027,000 | $19,892,000 | $15,906,000 |
| Gross Profit | $10,109,000 | $7,386,000 | $5,672,000 | $4,448,000 |
| % Margin | 30.4% | 28% | 22.2% | 21.9% |
| R&D Expenses | $0 | $260,000 | $260,000 | $264,000 |
| G&A Expenses | $1,740,000 | $1,487,000 | $1,418,000 | $0 |
| SG&A Expenses | $2,105,000 | $1,789,000 | $1,624,000 | $1,443,000 |
| Sales & Mktg Exp. | $365,000 | $302,000 | $206,000 | $0 |
| Other Operating Expenses | $345,000 | $41,000 | $31,000 | $31,000 |
| Operating Expenses | $2,450,000 | $2,090,000 | $1,915,000 | $1,738,000 |
| Operating Income | $7,659,000 | $5,296,000 | $3,756,000 | $2,709,000 |
| % Margin | 23% | 20.1% | 14.7% | 13.3% |
| Other Income/Exp. Net | -$248,000 | -$96,000 | -$158,000 | -$118,000 |
| Pre-Tax Income | $7,411,000 | $5,200,000 | $3,599,000 | $2,592,000 |
| Tax Expense | $2,339,000 | $1,527,000 | $1,036,000 | $818,000 |
| Net Income | $5,071,000 | $3,672,000 | $2,562,000 | $1,773,000 |
| % Margin | 15.2% | 13.9% | 10% | 8.7% |
| EPS | 995.18 | 720.48 | 502.73 | 347.94 |
| % Growth | 38.1% | 43.3% | 44.5% | – |
| EPS Diluted | 995.18 | 720.48 | 502.73 | 347.94 |
| Weighted Avg Shares Out | 509,556 | 509,700 | 509,804 | 509,800 |
| Weighted Avg Shares Out Dil | 509,556 | 509,700 | 509,804 | 509,800 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,000 | $5,000 | $3,000 | $6,000 |
| Interest Expense | $2,000 | $1,000 | $1,000 | $1,000 |
| Depreciation & Amortization | $1,975,000 | $1,970,000 | $1,812,000 | $1,489,000 |
| EBITDA | $9,388,000 | $7,171,000 | $5,569,000 | $4,199,000 |
| % Margin | 28.2% | 27.1% | 21.8% | 20.6% |